Free Trial

Femasys (FEMY) Competitors

$1.04
-0.01 (-0.95%)
(As of 06/7/2024 ET)

FEMY vs. POCI, BLUA, KRMD, SRTS, HSAQ, ALUR, PDEX, NVNO, NSPR, and MGRM

Should you be buying Femasys stock or one of its competitors? The main competitors of Femasys include Precision Optics (POCI), BlueRiver Acquisition (BLUA), KORU Medical Systems (KRMD), Sensus Healthcare (SRTS), Health Sciences Acquisitions Co. 2 (HSAQ), Allurion Technologies (ALUR), Pro-Dex (PDEX), enVVeno Medical (NVNO), InspireMD (NSPR), and Monogram Orthopaedics (MGRM). These companies are all part of the "medical" sector.

Femasys vs.

Femasys (NASDAQ:FEMY) and Precision Optics (NASDAQ:POCI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, media sentiment, risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

Precision Optics has a net margin of -8.43% compared to Femasys' net margin of -1,420.59%. Precision Optics' return on equity of -19.07% beat Femasys' return on equity.

Company Net Margins Return on Equity Return on Assets
Femasys-1,420.59% -104.06% -73.32%
Precision Optics -8.43%-19.07%-11.81%

Femasys presently has a consensus price target of $11.67, suggesting a potential upside of 1,021.79%. Given Femasys' higher possible upside, analysts clearly believe Femasys is more favorable than Precision Optics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Femasys
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Precision Optics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

65.3% of Femasys shares are held by institutional investors. Comparatively, 13.7% of Precision Optics shares are held by institutional investors. 16.4% of Femasys shares are held by company insiders. Comparatively, 16.3% of Precision Optics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Precision Optics has higher revenue and earnings than Femasys. Precision Optics is trading at a lower price-to-earnings ratio than Femasys, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Femasys$1.07M21.60-$14.25M-$0.84-1.24
Precision Optics$21.05M1.80-$140K-$0.28-22.25

Femasys received 22 more outperform votes than Precision Optics when rated by MarketBeat users. Likewise, 64.71% of users gave Femasys an outperform vote while only 0.00% of users gave Precision Optics an outperform vote.

CompanyUnderperformOutperform
FemasysOutperform Votes
22
64.71%
Underperform Votes
12
35.29%
Precision OpticsOutperform Votes
No Votes
Underperform Votes
2
100.00%

Femasys has a beta of -2.79, indicating that its share price is 379% less volatile than the S&P 500. Comparatively, Precision Optics has a beta of 0.09, indicating that its share price is 91% less volatile than the S&P 500.

In the previous week, Femasys had 2 more articles in the media than Precision Optics. MarketBeat recorded 2 mentions for Femasys and 0 mentions for Precision Optics. Femasys' average media sentiment score of 0.33 beat Precision Optics' score of 0.00 indicating that Femasys is being referred to more favorably in the media.

Company Overall Sentiment
Femasys Neutral
Precision Optics Neutral

Summary

Femasys beats Precision Optics on 10 of the 17 factors compared between the two stocks.

Get Femasys News Delivered to You Automatically

Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FEMY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FEMY vs. The Competition

MetricFemasysSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$23.11M$3.92B$5.19B$8.17B
Dividend YieldN/A1.78%2.73%4.04%
P/E Ratio-1.2415.23169.7518.17
Price / Sales21.6064.622,430.3977.93
Price / CashN/A48.4535.0930.80
Price / Book1.224.314.964.33
Net Income-$14.25M$4.50M$110.27M$216.21M
7 Day Performance-11.86%-0.96%-0.96%-1.38%
1 Month Performance-26.76%-2.94%-1.11%-0.68%
1 Year Performance40.54%-18.01%-1.96%1.60%

Femasys Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
POCI
Precision Optics
0 of 5 stars
$6.43
-1.7%
N/A-9.1%$39.69M$21.05M-22.9684Positive News
BLUA
BlueRiver Acquisition
0 of 5 stars
$11.04
-0.5%
N/AN/A$96.92MN/A0.003Gap Down
KRMD
KORU Medical Systems
2.1265 of 5 stars
$2.13
+0.9%
$3.50
+64.3%
-41.7%$96.56M$28.52M-7.6182Positive News
SRTS
Sensus Healthcare
3.8005 of 5 stars
$5.42
-4.2%
$10.00
+84.5%
+114.1%$92.78M$24.41M18.6935Positive News
HSAQ
Health Sciences Acquisitions Co. 2
0 of 5 stars
$6.67
-4.7%
N/A-43.6%$74.78MN/A0.004Gap Up
ALUR
Allurion Technologies
2.3817 of 5 stars
$1.51
flat
$5.00
+231.1%
N/A$72.40M$53.47M-0.40501News Coverage
PDEX
Pro-Dex
0 of 5 stars
$19.71
+0.6%
N/A+6.1%$67.01M$46.09M33.98145Analyst Upgrade
News Coverage
Positive News
NVNO
enVVeno Medical
0.2996 of 5 stars
$4.77
-1.0%
N/A+63.0%$64.25MN/A-2.8719News Coverage
Positive News
NSPR
InspireMD
1.5521 of 5 stars
$2.64
+3.1%
$4.85
+83.7%
+59.2%$63.82M$6.20M-3.4765Gap Down
MGRM
Monogram Orthopaedics
0 of 5 stars
$1.99
-0.5%
N/A-48.1%$63.34M$370,000.00-3.9828Gap Up

Related Companies and Tools

This page (NASDAQ:FEMY) was last updated on 6/7/2024 by MarketBeat.com Staff

From Our Partners